Efficacy and Safety of Levetiracetam (3,000 mg/Day) as an Adjunctive Therapy in Chinese Patients with Refractory Partial Seizures

Publisher: Karger

E-ISSN: 1421-9913|61|4|233-239

ISSN: 0014-3022

Source: European Neurology, Vol.61, Iss.4, 2009-01, pp. : 233-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content